2018 Q1 Form 10-Q Financial Statement

#000149315218007038 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $4.201M $4.664M
YoY Change -9.92% -12.21%
Cost Of Revenue $2.234M $2.570M
YoY Change -13.07% -16.4%
Gross Profit $1.967M $2.094M
YoY Change -6.05% -6.46%
Gross Profit Margin 46.83% 44.9%
Selling, General & Admin $1.000M $1.010M
YoY Change -0.99% 16.09%
% of Gross Profit 50.83% 48.23%
Research & Development $37.21K $11.14K
YoY Change 233.87% -68.81%
% of Gross Profit 1.89% 0.53%
Depreciation & Amortization $55.59K $76.27K
YoY Change -27.11% -42.04%
% of Gross Profit 2.83% 3.64%
Operating Expenses $955.7K $1.042M
YoY Change -8.29% 10.99%
Operating Profit $1.012M $1.052M
YoY Change -3.84% -19.07%
Interest Expense $7.400K $11.57K
YoY Change -36.02% 5.69%
% of Operating Profit 0.73% 1.1%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $1.006M $3.573M
YoY Change -71.86% 174.88%
Income Tax $301.9K $296.9K
% Of Pretax Income 30.02% 8.31%
Net Earnings $703.7K $3.253M
YoY Change -78.37% 338.49%
Net Earnings / Revenue 16.75% 69.74%
Basic Earnings Per Share
Diluted Earnings Per Share $59.07K $279.2K
COMMON SHARES
Basic Shares Outstanding 11.62M shares 11.46M shares
Diluted Shares Outstanding 11.85M shares 11.64M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.610M $4.870M
YoY Change 35.73% 289.6%
Cash & Equivalents $6.614M $4.869M
Short-Term Investments
Other Short-Term Assets $170.0K $180.0K
YoY Change -5.56% 28.57%
Inventory $4.789M $4.539M
Prepaid Expenses $165.9K $182.1K
Receivables $2.566M $3.393M
Other Receivables $0.00 $1.570M
Total Short-Term Assets $14.14M $14.55M
YoY Change -2.88% 89.61%
LONG-TERM ASSETS
Property, Plant & Equipment $1.877M $1.714M
YoY Change 9.53% -55.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.164K $140.0K
YoY Change -94.88% 1300.0%
Other Assets $1.760M $2.470M
YoY Change -28.74% 24.12%
Total Long-Term Assets $3.742M $4.422M
YoY Change -15.37% -26.22%
TOTAL ASSETS
Total Short-Term Assets $14.14M $14.55M
Total Long-Term Assets $3.742M $4.422M
Total Assets $17.88M $18.98M
YoY Change -5.79% 38.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $350.0K $760.0K
YoY Change -53.95% -19.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $250.0K $700.0K
YoY Change -64.29% 55.56%
Long-Term Debt Due $201.2K $201.2K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $2.208M $2.892M
YoY Change -23.64% 42.04%
LONG-TERM LIABILITIES
Long-Term Debt $100.6K $301.8K
YoY Change -66.67% -39.64%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.6K $301.8K
YoY Change -66.67% -39.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.208M $2.892M
Total Long-Term Liabilities $100.6K $301.8K
Total Liabilities $2.309M $3.194M
YoY Change -27.7% 25.78%
SHAREHOLDERS EQUITY
Retained Earnings $1.155M $1.950M
YoY Change -40.74% -182.8%
Common Stock $15.19M $14.88M
YoY Change 2.07% 0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.57M $15.78M
YoY Change
Total Liabilities & Shareholders Equity $17.88M $18.98M
YoY Change -5.79% 38.83%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $703.7K $3.253M
YoY Change -78.37% 338.49%
Depreciation, Depletion And Amortization $55.59K $76.27K
YoY Change -27.11% -42.04%
Cash From Operating Activities -$181.8K -$1.894M
YoY Change -90.4% -1115.86%
INVESTING ACTIVITIES
Capital Expenditures $7.497K $29.90K
YoY Change -74.93% -67.03%
Acquisitions
YoY Change
Other Investing Activities $10.00K $4.060M
YoY Change -99.75%
Cash From Investing Activities -$1.247K $4.030M
YoY Change -100.03% -4526.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $36.36K -$2.250K
YoY Change -1716.0% -100.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$13.94K $402.0K
YoY Change -103.47% -129.23%
NET CHANGE
Cash From Operating Activities -$181.8K -$1.894M
Cash From Investing Activities -$1.247K $4.030M
Cash From Financing Activities -$13.94K $402.0K
Net Change In Cash -$197.0K $2.538M
YoY Change -107.76% -298.28%
FREE CASH FLOW
Cash From Operating Activities -$181.8K -$1.894M
Capital Expenditures $7.497K $29.90K
Free Cash Flow -$189.3K -$1.924M
YoY Change -90.16% -2109.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11630991 shares
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6912138 usd
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2470066 usd
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6613875 usd
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4869420 usd
CY2017Q4 us-gaap Inventory Net
InventoryNet
4686852 usd
CY2018Q1 us-gaap Inventory Net
InventoryNet
4789409 usd
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
255080 usd
CY2018Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
165928 usd
CY2017Q4 us-gaap Assets Current
AssetsCurrent
13959541 usd
CY2018Q1 us-gaap Assets Current
AssetsCurrent
14135710 usd
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1938509 usd
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1877044 usd
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79452 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75342 usd
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18531 usd
CY2018Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18498 usd
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1763923 usd
CY2018Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1763923 usd
CY2017Q4 us-gaap Assets
Assets
17773370 usd
CY2018Q1 us-gaap Assets
Assets
17877681 usd
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
939116 usd
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
351126 usd
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
208608 usd
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2616 usd
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1101596 usd
CY2018Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1403492 usd
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
201193 usd
CY2018Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
201193 usd
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2700513 usd
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2208427 usd
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
150896 usd
CY2018Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
100598 usd
CY2017Q4 us-gaap Liabilities
Liabilities
2851409 usd
CY2018Q1 us-gaap Liabilities
Liabilities
2309025 usd
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11598 usd
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
11631 usd
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15114835 usd
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15176862 usd
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
451621 usd
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1155285 usd
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
14921961 usd
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
15568656 usd
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17773370 usd
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17877681 usd
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11597991 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11630991 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11597991 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11630991 shares
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4210180 usd
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
4663708 usd
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2233917 usd
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2569675 usd
CY2018Q1 us-gaap Gross Profit
GrossProfit
1967263 usd
CY2017Q1 us-gaap Gross Profit
GrossProfit
2094033 usd
CY2018Q1 us-gaap Salaries And Wages
SalariesAndWages
421310 usd
CY2017Q1 us-gaap Salaries And Wages
SalariesAndWages
358417 usd
CY2018Q1 us-gaap Officers Compensation
OfficersCompensation
260593 usd
CY2017Q1 us-gaap Officers Compensation
OfficersCompensation
249082 usd
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4343 usd
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9577 usd
CY2018Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
35655 usd
CY2017Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
37341 usd
CY2018Q1 us-gaap Other General Expense
OtherGeneralExpense
29673 usd
CY2017Q1 us-gaap Other General Expense
OtherGeneralExpense
34902 usd
CY2018Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
62778 usd
CY2017Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
81609 usd
CY2018Q1 us-gaap Interest Expense
InterestExpense
7400 usd
CY2017Q1 us-gaap Interest Expense
InterestExpense
11567 usd
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
61742 usd
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
55514 usd
CY2018Q1 FSI Consulting
Consulting
32854 usd
CY2017Q1 FSI Consulting
Consulting
34296 usd
CY2018Q1 us-gaap Professional Fees
ProfessionalFees
43314 usd
CY2017Q1 us-gaap Professional Fees
ProfessionalFees
57552 usd
CY2018Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
30150 usd
CY2017Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
33899 usd
CY2018Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
6156 usd
CY2017Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
6296 usd
CY2018Q1 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
4109 usd
CY2017Q1 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
3862 usd
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37206 usd
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11144 usd
CY2018Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
usd
CY2017Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
40655 usd
CY2018Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
usd
CY2017Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
380 usd
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
86134 usd
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9004 usd
CY2018Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
4535 usd
CY2017Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
6965 usd
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
955684 usd
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1042062 usd
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
277482 usd
CY2018Q1 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
51346 usd
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1697 usd
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
33 usd
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1005560 usd
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3572946 usd
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301896 usd
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
296875 usd
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
703664 usd
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
3252667 usd
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-119029 usd
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39667 usd
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
584635 usd
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3292334 usd
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11620291 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11458170 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11847061 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11638732 shares
CY2018Q1 us-gaap Profit Loss
ProfitLoss
703664 usd
CY2017Q1 us-gaap Profit Loss
ProfitLoss
3252667 usd
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25700 usd
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
23482 usd
CY2018Q1 FSI Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
usd
CY2018Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
301896 usd
CY2017Q1 FSI Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-23404 usd
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
467008 usd
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1975550 usd
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
111400 usd
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
925992 usd
CY2018Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-88612 usd
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-47193 usd
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
296875 usd
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-205920 usd
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52499 usd
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-181777 usd
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1894207 usd
CY2018Q1 us-gaap Proceeds From Sale Of Insurance Investments
ProceedsFromSaleOfInsuranceInvestments
usd
CY2017Q1 us-gaap Proceeds From Sale Of Insurance Investments
ProceedsFromSaleOfInsuranceInvestments
4053612 usd
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1247 usd
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4029959 usd
CY2018Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
450000 usd
CY2018Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-50298 usd
CY2017Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-50298 usd
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
36360 usd
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2250 usd
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13938 usd
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
401952 usd
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-101301 usd
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-138350 usd
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-298263 usd
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2399354 usd
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
7356 usd
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
11567 usd
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2145803 usd
CY2018Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2605742 usd
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40332 usd
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39244 usd
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2105471 usd
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2566498 usd
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2530914 usd
CY2018Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2555914 usd
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
183944 usd
CY2018Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6652801 usd
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6650472 usd
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4714292 usd
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4773428 usd
CY2017Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
212426 usd
CY2018Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
205613 usd
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
132974 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
130271 usd
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4110 usd
CY2017Q4 FSI Equity Method Investment1
EquityMethodInvestment1
13414 usd
CY2016Q4 FSI Equity Method Investment1
EquityMethodInvestment1
122480 usd
CY2018Q1 FSI Equity Method Investment1
EquityMethodInvestment1
7164 usd
CY2017 FSI Equity Method Investment Return Of Equity
EquityMethodInvestmentReturnOfEquity
-25000 usd
CY2018Q1 FSI Equity Method Investment Return Of Equity
EquityMethodInvestmentReturnOfEquity
-6250 usd
CY2017 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-84066 usd
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
250000 usd
CY2018Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
250000 usd
CY2017Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
CY2017Q4 FSI Balance Owing
BalanceOwing
352089 usd
CY2018Q1 FSI Balance Owing
BalanceOwing
301791 usd
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
352089 usd
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
553282 usd
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
301791 usd
CY2017 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
201193 usd
CY2018Q1 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
50298 usd
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1011579 usd
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1051971 usd
CY2017Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1971994 usd
CY2018Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2233495 usd
CY2018Q1 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
2429695 usd
CY2017Q1 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
4207578 usd
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59700 usd
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
80375 usd
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify">&#160;</td> <td style="width: 34px; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(l)</font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use of Estimates.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.3pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the asset impairment analysis, share-based payments and warrants, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds, and the valuation of inventory.</p>
CY2018Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&#160;</td> <td style="width: 34px; font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(q) </font></td> <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Risk Management.</i></font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company&#8217;s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Accounts receivable for the Company&#8217;s three primary customers totaled $1,133,325 (44%) at March 31, 2018 (December 31, 2017 - $1,247,374 or 65%).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">The credit risk on cash and cash equivalents is limited because the Company limits its exposure to credit loss by placing its cash and cash equivalents with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any material losses in such accounts.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">The Company is exposed to foreign exchange and interest rate risk to the extent that market value rate fluctuations materially differ from financial assets and liabilities, subject to fixed long-term rates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</p>
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1.00 pure
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
140000 shares
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
33000 shares
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
77099 usd
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M0D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
713000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
813000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
680000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
154000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-114000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2018Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Cancelled Or Expired Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledOrExpiredOptionsExercisePrice
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.19
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.22
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.70
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.75
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.11
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.10
CY2018Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 segments
CY2018Q1 FSI Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
1952386 usd
CY2017Q1 FSI Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
1805504 usd
CY2018Q1 us-gaap Revenues
Revenues
4201180 usd
CY2017Q1 us-gaap Revenues
Revenues
4663708 usd
CY2017Q4 FSI Property Equipment Leasehold And Patents
PropertyEquipmentLeaseholdAndPatents
2017961 usd
CY2018Q1 FSI Property Equipment Leasehold And Patents
PropertyEquipmentLeaseholdAndPatents
1952386 usd
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
685315 usd
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
13414 usd
CY2018Q1 us-gaap Equity Method Investments
EquityMethodInvestments
7164 usd
CY2018Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-6250 usd
CY2017Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-6250 usd
CY2017Q1 us-gaap Increase Decrease In Recoverable Property Damage Costs
IncreaseDecreaseInRecoverablePropertyDamageCosts
1659404 usd
CY2017 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
1.70
CY2018Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55590 usd
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76265 usd
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23404 usd
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
FLEXIBLE SOLUTIONS INTERNATIONAL INC
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001069394
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q1 dei Trading Symbol
TradingSymbol
FSI
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.28
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-577021 usd
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-91874 usd
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7497 usd
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29903 usd
CY2018Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P17Y
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
526000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.08
CY2018Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-7716 usd
CY2017Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
2572288 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
16438 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
16438 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16438 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16438 usd
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
16438 usd
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
150895 usd
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
150896 usd
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2018Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P3Y
CY2018Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-10-31
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
151485 usd
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
205580 usd
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
209400 usd
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
118850 usd
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-656093 usd
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-775122 usd
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0223 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7309 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.8344

Files In Submission

Name View Source Status
0001493152-18-007038-index-headers.html Edgar Link pending
0001493152-18-007038-index.html Edgar Link pending
0001493152-18-007038.txt Edgar Link pending
0001493152-18-007038-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
fsi-20180331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
fsi-20180331_cal.xml Edgar Link unprocessable
fsi-20180331_def.xml Edgar Link unprocessable
fsi-20180331_lab.xml Edgar Link unprocessable
fsi-20180331_pre.xml Edgar Link unprocessable
fsi-20180331.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable